Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis: What we know, What we don’t know, What we need to know for public health impact

Raphael J. Landovitz, MD MSc
Professor of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at UCLA
Co-Director, UCLA Center for Clinical AIDS Research and Education (CARE)
Co-Director, UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS)
University of California, Los Angeles, California, USA

Harvard CFAR Virtual Grants Rounds
July 30, 2020
11 a.m.–12 p.m. CT
Reservation Required
Discussion and Q&A moderated by Dr. Kenneth Mayer, MD

Dr. Landovitz received his BA in Chemistry from Princeton University (Princeton, New Jersey, USA), and received his medical degree from Harvard Medical School (Boston, Massachusetts, USA). Following this, he completed an internship, residency, and served as Chief Resident in Internal Medicine at Brigham and Women’s Hospital (Boston, Massachusetts, USA) and an Infectious Diseases fellowship with Brigham and Women’s Hospital and Massachusetts General Hospital (Boston, Massachusetts, USA). He served as Medical Co-Director of the Vietnam-CDC-Harvard Medical School-AIDS-Partnership (VCHAP), helping to train Vietnamese physicians in HIV care and treatment. He is an infectious disease and HIV clinician and clinical investigator whose research interests include HIV prevention (including pre- and post-exposure prophylaxis and other combination prevention strategies) and the impact of such prevention interventions on risk behavior. Dr. Landovitz works with the United States National Institutes of Health (NIH)-funded Division of AIDS (DAIDS) clinical trials networks for HIV therapeutics and HIV Prevention. He is has led numerous clinical trials, and currently leads the NIH trials developing long-acting injectable cabotegravir for HIV prevention. In 2010, he was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010, and the American Association of HIV Medicine Research Award in 2017. Dr. Landovitz is the Co-director of the UCLA Center for Clinical AIDS Research & Education (CARE) and of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS).

The presentation will be followed by a brief Q&A Session moderated by Dr. Kenneth Mayer, MD. Dr. Mayer is Director of the HU CFAR Bio-Behavioral and Community Science Core, Medical Research Director and Co-Chair of The Fenway Institute,
Professor of Medicine at Harvard Medical School and Professor, Department of Global Health and Population at Harvard School of Public Health.